Acromegaly and Cushing’s Drugs Sold to Italian Pharma Company

Written on 24 July 2019.

An article in fiercepharma.com discusses the sale by Novartis of the drugs Signifor, Signifor LAR and osilodrostat to an Italian drugmaker called Recordati for $390 million upfront. It is unclear how or if this will affect patients in terms of price or availability. Read more:
https://www.fiercepharma.com/pharma/novartis-offloads-lagging-endocrine-drugs-pipeline-followup-to-recordati-for-390m

Available Now!

The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now

PNA Gratefully Acknowledges our Supporters

Continuing Education Program

If you are a nurse or medical professional, register for PNA CEU Membership and earn CEU credits to learn about the symptoms, diagnosis and treatment options for patients with pituitary disorders. Help PNA reduce the time it takes for patients to get an accurate diagnosis.